Detalhe da pesquisa
1.
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program.
Epilepsia
; 64(8): e156-e163, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243404
2.
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 391(10125): 1085-1096, 2018 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29395273
3.
The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis.
Epilepsy Behav
; 93: 65-72, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30831405
4.
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.
Epilepsia
; 59(8): 1540-1548, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29998598
5.
Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods.
Schizophr Res
; 87(1-3): 32-44, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16887335
6.
African-American community attitudes and perceptions toward schizophrenia and medical research: an exploratory study.
J Natl Med Assoc
; 98(1): 18-27, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16532974
7.
Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients.
Am J Psychiatry
; 167(4): 459-72, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20194479